TY - JOUR
T1 - Fecal electrolyte testing for evaluation of unexplained diarrhea
T2 - Validation of body fluid test accuracy in the absence of a reference method
AU - Voskoboev, Nikolay V.
AU - Cambern, Sarah J.
AU - Hanley, Matthew M.
AU - Giesen, Callen D.
AU - Schilling, Jason J.
AU - Jannetto, Paul J.
AU - Lieske, John C.
AU - Block, Darci R.
N1 - Funding Information:
This study was supported by the Mayo Foundation . The authors gratefully acknowledge support from staff of Renal Testing and Metals Laboratories and Specimen Collection Facility of the Mayo Clinic.
Publisher Copyright:
© 2015 The Canadian Society of Clinical Chemists.
PY - 2015/11/1
Y1 - 2015/11/1
N2 - BackgroundValidation of tests performed on body fluids other than blood or urine can be challenging due to the lack of a reference method to confirm accuracy. The aim of this study was to evaluate alternate assessments of accuracy that laboratories can rely on to validate body fluid tests in the absence of a reference method using the example of sodium (Na+), potassium (K+), and magnesium (Mg2+) testing in stool fluid. MethodsValidations of fecal Na+, K+, and Mg2+ were performed on the Roche cobas 6000 c501 (Roche Diagnostics) using residual stool specimens submitted for clinical testing. Spiked recovery, mixing studies, and serial dilutions were performed and % recovery of each analyte was calculated to assess accuracy. Results were confirmed by comparison to a reference method (ICP-OES, PerkinElmer). ResultsMean recoveries for fecal electrolytes were Na+ upon spiking=92%, mixing=104%, and dilution=105%; K+ upon spiking=94%, mixing=96%, and dilution=100%; and Mg2+ upon spiking=93%, mixing=98%, and dilution=100%. When autoanalyzer results were compared to reference ICP-OES results, Na+ had a slope=0.94, intercept=4.1, and R2=0.99; K+ had a slope=0.99, intercept=0.7, and R2=0.99; and Mg2+ had a slope=0.91, intercept=-4.6, and R2=0.91. Calculated osmotic gap using both methods were highly correlated with slope=0.95, intercept=4.5, and R2=0.97. Acid pretreatment increased magnesium recovery from a subset of clinical specimens. ConclusionsA combination of mixing, spiking, and dilution recovery experiments are an acceptable surrogate for assessing accuracy in body fluid validations in the absence of a reference method.
AB - BackgroundValidation of tests performed on body fluids other than blood or urine can be challenging due to the lack of a reference method to confirm accuracy. The aim of this study was to evaluate alternate assessments of accuracy that laboratories can rely on to validate body fluid tests in the absence of a reference method using the example of sodium (Na+), potassium (K+), and magnesium (Mg2+) testing in stool fluid. MethodsValidations of fecal Na+, K+, and Mg2+ were performed on the Roche cobas 6000 c501 (Roche Diagnostics) using residual stool specimens submitted for clinical testing. Spiked recovery, mixing studies, and serial dilutions were performed and % recovery of each analyte was calculated to assess accuracy. Results were confirmed by comparison to a reference method (ICP-OES, PerkinElmer). ResultsMean recoveries for fecal electrolytes were Na+ upon spiking=92%, mixing=104%, and dilution=105%; K+ upon spiking=94%, mixing=96%, and dilution=100%; and Mg2+ upon spiking=93%, mixing=98%, and dilution=100%. When autoanalyzer results were compared to reference ICP-OES results, Na+ had a slope=0.94, intercept=4.1, and R2=0.99; K+ had a slope=0.99, intercept=0.7, and R2=0.99; and Mg2+ had a slope=0.91, intercept=-4.6, and R2=0.91. Calculated osmotic gap using both methods were highly correlated with slope=0.95, intercept=4.5, and R2=0.97. Acid pretreatment increased magnesium recovery from a subset of clinical specimens. ConclusionsA combination of mixing, spiking, and dilution recovery experiments are an acceptable surrogate for assessing accuracy in body fluid validations in the absence of a reference method.
KW - Body fluid
KW - Chronic diarrhea
KW - Cobas
KW - Electrolytes
KW - ICP-OES
KW - Validation
UR - http://www.scopus.com/inward/record.url?scp=84947034376&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84947034376&partnerID=8YFLogxK
U2 - 10.1016/j.clinbiochem.2015.06.011
DO - 10.1016/j.clinbiochem.2015.06.011
M3 - Article
C2 - 26093046
AN - SCOPUS:84947034376
SN - 0009-9120
VL - 48
SP - 1126
EP - 1130
JO - Clinical Biochemistry
JF - Clinical Biochemistry
IS - 16-17
ER -